Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

HVO

Hvivo (HVO)

Hvivo Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:HVO
FechaHoraFuenteTítuloSímboloCompañía
15/04/202401:00RNS Regulatory NewshVIVO PLC Annual Report & Notice of AGMLSE:HVOHvivo Plc
09/04/202406:03Alliance NewsAlliance NewshVIVO swings to profit and commences annual dividends as outlook rosyLSE:HVOHvivo Plc
09/04/202401:09RNS Regulatory NewshVIVO PLC Final resultsLSE:HVOHvivo Plc
27/03/202402:00RNS Regulatory NewshVIVO PLC Notice of ResultsLSE:HVOHvivo Plc
22/03/202410:03RNS Regulatory NewshVIVO PLC Holding(s) in CompanyLSE:HVOHvivo Plc
15/02/202401:00RNS Regulatory NewshVIVO PLC Long Term Incentive Plan / PDMR NotificationLSE:HVOHvivo Plc
14/02/202413:55Alliance NewsAlliance NewsIN BRIEF: hVIVO Chair and non-exec director sell 30.0 million sharesLSE:HVOHvivo Plc
14/02/202407:14RNS Regulatory NewshVIVO PLC Result of Secondary PlacingLSE:HVOHvivo Plc
14/02/202404:46Alliance NewsAlliance NewsIN BRIEF: hVIVO directors to sell total of 14 million sharesLSE:HVOHvivo Plc
14/02/202401:00RNS Regulatory NewshVIVO PLC Proposed Secondary Placing of Ordinary SharesLSE:HVOHvivo Plc
30/01/202405:39Alliance NewsAlliance NewshVIVO shares up after "record year" across all metricsLSE:HVOHvivo Plc
30/01/202401:00RNS Regulatory NewshVIVO PLC Trading updateLSE:HVOHvivo Plc
08/01/202401:00UK RegulatoryhVIVO PLC Broker changeLSE:HVOHvivo Plc
02/01/202404:16Alliance NewsAlliance NewshVIVO inks GBP6.3 million deal to test common cold treatmentLSE:HVOHvivo Plc
02/01/202401:00UK RegulatoryhVIVO PLC GBP6.3m HRV contract signed with biotech clientLSE:HVOHvivo Plc
13/12/202305:44Alliance NewsAlliance NewshVIVO signs deal to test RSV antiviral drug candidate with study modelLSE:HVOHvivo Plc
13/12/202301:00UK RegulatoryhVIVO PLC GBP16.8m RSV contract & Trading ahead of guidanceLSE:HVOHvivo Plc
05/10/202305:45Alliance NewsAlliance NewshVIVO celebrates positive results for Pneumagen's Neumifil in trialLSE:HVOHvivo Plc
05/10/202301:00RNS Non-RegulatoryhVIVO PLC Positive results from flu human challenge studyLSE:HVOHvivo Plc
12/09/202305:33Alliance NewsAlliance NewshVIVO interim profit jumps on revenue increase; ups full-year guidanceLSE:HVOHvivo Plc
12/09/202301:00UK RegulatoryhVIVO PLC Interim resultsLSE:HVOHvivo Plc
01/09/202301:00UK RegulatoryhVIVO PLC Exercise of WarrantsLSE:HVOHvivo Plc
29/08/202305:32Alliance NewsAlliance NewshVIVO announces plans for new Canary Wharf facility as demand growsLSE:HVOHvivo Plc
29/08/202301:00UK RegulatoryhVIVO PLC Plans for a new larger state-of-the-art facilityLSE:HVOHvivo Plc
26/07/202308:29Alliance NewsAlliance NewsIN BRIEF: hVIVO interim revenue grows; in line with expectationsLSE:HVOHvivo Plc
25/07/202308:25Alliance NewsAlliance NewshVIVO secures GBP13.1 million contract for influenza B modelLSE:HVOHvivo Plc
25/07/202301:00UK RegulatoryhVIVO PLC Flu B challenge modelLSE:HVOHvivo Plc
28/06/202308:16Alliance NewsAlliance NewshVIVO inks deal to manufacture human hMPV virus for challenge trialLSE:HVOHvivo Plc
28/06/202301:00UK RegulatoryhVIVO PLC hMPV human challenge modelLSE:HVOHvivo Plc
14/06/202302:00UK RegulatoryhVIVO PLC Director dealingsLSE:HVOHvivo Plc
 Showing the most relevant articles for your search:LSE:HVO